Sigyn Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Sigyn Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $12.1 thousand for the year ending 2024.

  • Sigyn Therapeutics, Inc. showed an increase of +3.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Sigyn Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2014 to 2024), Sigyn Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 12,683.2%.
  • Historical annual values: Fiscal year 2024: $12.1 thousand | Fiscal year 2023: $11.7 thousand | Fiscal year 2022: $8.4 thousand | Fiscal year 2021: $341.0 thousand | Fiscal year 2020: $84.4 thousand | Fiscal year 2019: $500.00 | Fiscal year 2018: $7.5 thousand | Fiscal year 2017: $9.6 thousand | Fiscal year 2016: $149.6 thousand | Fiscal year 2015: $638.8 thousand | Fiscal year 2014: $95.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: